Repression of the miR‐17‐92 cluster by p53 has an important function in hypoxia‐induced apoptosis
暂无分享,去创建一个
Ying Tang | Ming-Hua Lu | Shuhan Sun | Hong-Li Yan | G. Xue | Q. Mei | Yu-zhao Wang | Fei-xiang Ding | Mohan Liu | Ming-hua Lu | Ying Tang | Hong-yu Yu | Qian Mei | Hong-li Yan | Geng Xue | Yu-zhao Wang | Fei-xiang Ding | Mo-Fang Liu | Hong-yu Yu | Shu-han Sun | Hong-li Yan | Yu‐zhao Wang
[1] A. Levine,et al. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. , 1996, Genes & development.
[2] Yoichi Taya,et al. Regulation of p53 by Hypoxia: Dissociation of Transcriptional Repression and Apoptosis from p53-Dependent Transactivation , 2001, Molecular and Cellular Biology.
[3] S. Benchimol,et al. Transcriptional repression mediated by the p53 tumour suppressor , 2003, Cell Death and Differentiation.
[4] Amato J Giaccia,et al. The role of p53 in hypoxia-induced apoptosis. , 2005, Biochemical and biophysical research communications.
[5] 林下 陽二. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation , 2006 .
[6] C. Croce,et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Karsan,et al. Mechanisms of Hypoxia-induced Endothelial Cell Death , 1999, The Journal of Biological Chemistry.
[8] A. Giaccia,et al. Genetic determinants that influence hypoxia-induced apoptosis. , 2001, Novartis Foundation symposium.
[9] C. Croce,et al. miRNAs, Cancer, and Stem Cell Division , 2005, Cell.
[10] M. Mareel,et al. Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco‐2 cells , 1997, FEBS letters.
[11] George A. Calin,et al. A MicroRNA Signature of Hypoxia , 2006, Molecular and Cellular Biology.
[12] Avner Friedman,et al. MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc , 2008, Proceedings of the National Academy of Sciences.
[13] P. Nilsson,et al. Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis , 2007, Cell Death and Differentiation.
[14] A. Giaccia,et al. Functional Analysis of p53 Binding under Differential Stresses , 2006, Molecular and Cellular Biology.
[15] Jiandong Chen,et al. Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53* , 2002, The Journal of Biological Chemistry.
[16] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[17] Vladimir Benes,et al. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). , 2006, RNA.
[18] Joshua J. Forman,et al. “Myc’ed Messages”: Myc Induces Transcription of E2F1 while Inhibiting Its Translation via a microRNA Polycistron , 2007, PLoS genetics.
[19] E. Furth,et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster , 2006, Nature Genetics.
[20] Ronald A. DePinho,et al. p53: good cop/bad cop. , 2002, Cell.
[21] Carme Camps,et al. hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer , 2008, Clinical Cancer Research.
[22] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[23] Kevin Struhl,et al. Quantitative sequential chromatin immunoprecipitation, a method for analyzing co-occupancy of proteins at genomic regions in vivo. , 2004, Nucleic acids research.
[24] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[25] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[26] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[27] Weili Ma,et al. p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest , 2005, Molecular and Cellular Biology.
[28] Erwin G. Van Meir. Hypoxia-mediated selection of cells with diminished apoptotic potential to solid tumours. , 1996, Neurosurgery.
[29] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[30] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[31] J. Weinberg,et al. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury , 1998, Oncogene.
[32] G. Sluder,et al. Cell-Cycle Progression without an Intact Microtubule Cytoskeleton , 2007, Current Biology.
[33] 高倉 修. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells , 2008 .
[34] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[35] A. Donfrancesco,et al. Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM , 2008, PloS one.
[36] K. Kinzler,et al. Definition of a consensus binding site for p53 , 1992, Nature Genetics.
[37] K. Kinzler,et al. PUMA mediates the apoptotic response to p53 in colorectal cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[38] Alberto Riva,et al. MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes , 2005, BMC Bioinformatics.
[39] C. Belka,et al. Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathways , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] V. Zachar,et al. Instability of standard PCR reference genes in adipose-derived stem cells during propagation, differentiation and hypoxic exposure , 2008, BMC Molecular Biology.
[41] Jing Wang,et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes , 2008, Nature Immunology.
[42] T Takahashi,et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 , 2007, Oncogene.
[43] M. Kastan,et al. Role of p53 in apoptosis. , 1997, Advances in pharmacology.
[44] M. Byrom,et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.
[45] Peter F Stadler,et al. Molecular evolution of a microRNA cluster. , 2004, Journal of molecular biology.
[46] E. White,et al. Bcl-2 blocks p53-dependent apoptosis , 1994, Molecular and cellular biology.
[47] F. Chapon,et al. Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents. , 2005, Mutagenesis.
[48] K. Kinzler,et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. , 1999, The Journal of clinical investigation.
[49] N. Altorki,et al. Inhibition of Cyclooxygenase-2 Gene Expression by p53* , 1999, The Journal of Biological Chemistry.
[50] Arnold J Levine,et al. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. , 2002, Genes & development.
[51] E. Slee,et al. To die or not to die: how does p53 decide? , 2004, Oncogene.
[52] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[53] J. M. Thomson,et al. Direct Regulation of an Oncogenic Micro-RNA Cluster by E2F Transcription Factors* , 2007, Journal of Biological Chemistry.
[54] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[55] Yaolin Wang,et al. Analyses of p53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches* 210 , 2001, The Journal of Biological Chemistry.